Renaissance Technologies - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 95 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2022$728,000
-91.6%
25,888
-83.9%
0.00%
-90.9%
Q3 2021$8,707,000
-28.5%
161,276
-55.7%
0.01%
-26.7%
Q2 2021$12,173,000
+9.1%
364,027
-32.8%
0.02%
+7.1%
Q1 2021$11,153,000
-39.3%
541,427
-48.4%
0.01%
-30.0%
Q4 2020$18,375,000
-28.7%
1,048,827
-39.6%
0.02%
-23.1%
Q3 2020$25,755,000
+21.0%
1,736,675
+6.1%
0.03%
+44.4%
Q2 2020$21,283,000
+995.4%
1,637,175
+39.9%
0.02%
+800.0%
Q1 2020$1,943,000
-21.9%
1,170,187
+4.9%
0.00%0.0%
Q4 2019$2,487,000
+13.8%
1,115,368
+8.7%
0.00%0.0%
Q3 2019$2,186,000
-10.6%
1,026,285
+12.5%
0.00%0.0%
Q2 2019$2,445,000
-8.8%
912,285
+67.4%
0.00%0.0%
Q1 2019$2,682,000545,1060.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q3 2020
NameSharesValueWeighting ↓
Kynam Capital Management, LP 3,200,000$88,064,00014.40%
Octagon Capital Advisors LP 759,898$20,912,3933.21%
TSP Capital Management Group, LLC 251,695$6,926,6452.67%
5AM Venture Management, LLC 310,270$8,538,6302.46%
COMMODORE CAPITAL LP 706,665$19,447,4212.27%
ACUTA CAPITAL PARTNERS, LLC 122,341$3,366,8242.26%
Redmile Group, LLC 1,635,938$45,021,0142.14%
RTW INVESTMENTS, LP 3,463,201$95,307,2922.01%
Eversept Partners, LP 588,143$16,185,6951.37%
Affinity Asset Advisors, LLC 150,000$4,128,0001.16%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders